SCHEMBL7248709

SCHEMBL7248709

NCC1(CC(=O)NO)CCN(Cc2ccccc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPFFR1 Q9GZQ6 6/20 0.51
NPFFR2 Q9Y5X5 6/20 0.51
OPRK1 P41145 1/20 0.51
HDAC4 P56524 1/20 0.50
KCNH2 Q12809 1/20 0.50
HDAC1 Q13547 1/20 0.50
CYP2D6 P10635 3/20 0.49
ALDH1A1 P00352 2/20 0.49
TSHR P16473 1/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.47
CHRM2 P08172 2/20 0.47
CHRM3 P20309 1/20 0.47
HTR1A P08908 1/20 0.47
HTR7 P34969 1/20 0.47
OPRL1 P41146 2/20 0.47
CYP3A4 P08684 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3334062 0.81 SIGMAR1 (0.61) CYP2D6ALDH1A1TSHRKMT2AMEN1
SCHEMBL7248229 0.80 NPFFR1 (0.60) NPFFR1NPFFR2OPRK1
SCHEMBL6079469 0.79 POLB (0.59) ALDH1A1TSHRKMT2AMEN1OPRL1
SCHEMBL7249627 0.78 MAPK1 (0.50) NPFFR1NPFFR2OPRK1CYP2D6ALDH1A1
SCHEMBL7251032 0.78 NPFFR1 (0.56) NPFFR1NPFFR2OPRK1CYP2D6ALDH1A1
SCHEMBL4630842 0.77 POLB (0.57) NPFFR1NPFFR2OPRK1ALDH1A1TSHR
SCHEMBL2524338 0.77 CYP2D6 (0.57) NPFFR1NPFFR2CYP2D6ALDH1A1TSHR
SCHEMBL7253609 0.77 CYP3A4 (0.49) CYP2D6ALDH1A1TSHRKMT2AMEN1
SCHEMBL20571382 0.76 CYP3A4 (0.54) NPFFR1NPFFR2OPRK1CYP2D6ALDH1A1
Hydrochloric Acid SCHEMBL4481783 0.76 POLB (0.58) NPFFR1NPFFR2CYP2D6ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045834-A1 4(3)SUBSTITUTED-4(3)-AMINOMETHYL-(THIO)PYRAN OR -PIPERIDINE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS WARNER-LAMBERT COMPANY (US) 2000-10-25 EP claimed
WO-1999031057-A1 4(3)SUBSTITUTED-4(3)-AMINOMETHYL-(THIO)PYRAN OR -PIPERIDINE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS WARNER-LAMBERT COMPANY (US) 1999-06-24 WO claimed
US-6545022-B1 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders PFIZER INC. 2003-04-08 US disclosed
EP-1045834-A1 4(3)SUBSTITUTED-4(3)-AMINOMETHYL-(THIO)PYRAN OR -PIPERIDINE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS WARNER-LAMBERT COMPANY (US) 2000-10-25 EP disclosed
WO-1999031057-A1 4(3)SUBSTITUTED-4(3)-AMINOMETHYL-(THIO)PYRAN OR -PIPERIDINE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS WARNER-LAMBERT COMPANY (US) 1999-06-24 WO disclosed